Have a personal or library account? Click to login
Assessment of hepatic prostaglandin E2 level in carbamazepine induced liver injury Cover

Assessment of hepatic prostaglandin E2 level in carbamazepine induced liver injury

Endocrine Regulations
Volume 56 (2022): Issue 1 (January 2022)
By: Ken-ichi Oba,  Hiroaki Shimada,  Ryota Hashimoto,  Atsushi Kawase,  Takeo Nakanishi and  Masahiro Iwaki  
Open Access
|Feb 2022

Authors

Ken-ichi Oba

Department of Pharmacy, Faculty of Pharmacy, Kindai University, Osaka, Japan

Hiroaki Shimada

Department of Pharmacy, Faculty of Pharmacy, Kindai University, Osaka, Japan

Ryota Hashimoto

Department of Pharmacy, Faculty of Pharmacy, Kindai University, Osaka, Japan

Atsushi Kawase

Department of Pharmacy, Faculty of Pharmacy, Kindai University, Osaka, Japan

Takeo Nakanishi

Department of Pharmacy, Faculty of Pharmacy, Takasaki University of Health and Welfare, Takasaki, Japan

Masahiro Iwaki

iwaki@phar.kindai.ac.jp

Department of Pharmacy, Faculty of Pharmacy, Kindai University, Osaka, Japan
Pharmaceutical Research and Technology Institute, Kindai University, Osaka, Japan
Antiaging Center, Kindai University, Osaka, Japan
DOI: https://doi.org/10.2478/enr-2022-0003 | Journal eISSN: 1336-0329 | Journal ISSN: 1210-0668
Journal RSS Feed
Language: English
Page range: 22 - 30
Published on: Feb 18, 2022
Published by: Slovak Academy of Sciences, Institute of Experimental Endocrinology
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year
Keywords:
liver injury,
prostaglandin E,
carbamazepine,
15-PGDH
Related subjects:
Life sciences,
Molecular biology,
Neurobiology,
Medicine,
Basic medical science,
Basic medical science, other,
Clinical medicine,
Internal medicine,
Endocrinology, diabetology

© 2022 Ken-ichi Oba, Hiroaki Shimada, Ryota Hashimoto, Atsushi Kawase, Takeo Nakanishi, Masahiro Iwaki, published by Slovak Academy of Sciences, Institute of Experimental Endocrinology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Previous articleVolume 56 (2022): Issue 1 (January 2022)Next article